关于：荷兰人乳头瘤病毒疫苗接种的成本效益分析。 - Suppr | 超能文献

Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

作者信息

Coupé Veerle M H, Meijer Chris J L M, Berkhof Johannes

出版信息

J Natl Cancer Inst. 2010 Mar 3;102(5):358; author reply 358. doi: 10.1093/jnci/djp372. Epub 2009 Oct 27.

DOI:10.1093/jnci/djp372

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.关于：荷兰人乳头瘤病毒疫苗接种的成本效益分析。

J Natl Cancer Inst. 2010 Mar 3;102(5):358; author reply 358. doi: 10.1093/jnci/djp372. Epub 2009 Oct 27.

2

Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.回复：关于荷兰人乳头瘤病毒疫苗接种的成本效益分析

J Natl Cancer Inst. 2010 Mar 3;102(5):358-9; author reply 359-60. doi: 10.1093/jnci/djp519.

3

Who should get the HPV vaccine? Usage expands amid debate.谁应该接种人乳头瘤病毒疫苗？在争论声中其使用范围不断扩大。

J Natl Cancer Inst. 2010 Jun 16;102(12):838-40. doi: 10.1093/jnci/djq229. Epub 2010 Jun 8.

4

Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.荷兰人乳头瘤病毒疫苗接种的成本效益分析

J Natl Cancer Inst. 2009 Aug 5;101(15):1083-92. doi: 10.1093/jnci/djp183. Epub 2009 Jul 1.

5

Cost-effectiveness of human papilloma virus vaccination in Iceland.冰岛人乳头瘤病毒疫苗接种的成本效益。

Acta Obstet Gynecol Scand. 2009;88(12):1411-6. doi: 10.3109/00016340903322750.

6

Cost-effectiveness analysis of Human Papillomavirus (HPV) vaccination in the Netherlands: recent publication reinforces favorable cost-effectiveness despite misleading conclusion.

Vaccine. 2010 Jan 22;28(4):873-4. doi: 10.1016/j.vaccine.2009.10.109. Epub 2009 Nov 5.

7

How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.在荷兰，人乳头瘤病毒16/18型疫苗接种后如何进行宫颈癌筛查。

Vaccine. 2009 Aug 13;27(37):5111-9. doi: 10.1016/j.vaccine.2009.06.043. Epub 2009 Jun 28.

8

[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].人乳头瘤病毒疫苗接种的效率——基于荷兰成本效益分析的估计

Ned Tijdschr Geneeskd. 2009;153:A356.

9

Primary and secondary prevention of cervical cancer--opportunities and challenges.宫颈癌的一级和二级预防——机遇与挑战

J Natl Cancer Inst. 2009 Apr 1;101(7):439-40. doi: 10.1093/jnci/djp044. Epub 2009 Mar 24.

10

Cost-utility analysis of vaccination against HPV in Israel.以色列人乳头瘤病毒疫苗接种的成本效用分析。

Vaccine. 2007 Sep 17;25(37-38):6677-91. doi: 10.1016/j.vaccine.2007.07.018. Epub 2007 Jul 30.

引用本文的文献

1

Modeling preventative strategies against human papillomavirus-related disease in developed countries.发达国家针对人乳头瘤病毒相关疾病的预防策略建模。

Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F157-67. doi: 10.1016/j.vaccine.2012.06.091.